Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, initially developed for the treatment of type 2 diabetes. However, its remarkable ability to aid in weight loss led to its FDA approval under the brand name Wegovy specifically for weight management in individuals with obesity or overweight conditions. Clinical trials showed that a 1 mg dose […]
Kategori Arşivleri: Semaglutide
You may be eligible for compounded semaglutide if branded Ozempic® or Wegovy® are on the FDA shortage list 4. Semaglutide (better known as Wegovy) may help people with obesity lose up to 25% of their body weight when used at a higher dose. In fact, the only way we’ve seen to get any kind of […]